ARCHIVES

NCI to Close Clinical Branch at Frederick, Move Patients, Protocols To Bethesda

This article is from The Cancer Letter archive.

Vol. 22 No. 20 | May 17, 1996

Download PDF Visit The Full Archive

Related Articles

New Compounds To Treat Gleevec-Resistant CML

January 26, 2007

FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly.

May 6, 2005

In Brief: Let Salaries Rise To Legal Levels, Biomedical Panel Says; Prostatic Cancer Blood Test Found

July 9, 1976

Shared Decisionmaking Called For In PSA Screening For Ages 55-69

May 31, 2013

Committee Drafts QRA Definition

November 19, 1982

Resolutions Urge Doubling Of NIH Budget From ’98 Level.

March 9, 2001